STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $395,000 | +174.3% | 30,738 | +102.5% | 0.03% | +211.1% |
| Q4 2018 | $144,000 | -37.9% | 15,181 | 0.0% | 0.01% | -43.8% |
| Q1 2018 | $232,000 | -38.0% | 15,181 | -36.7% | 0.02% | -61.0% |
| Q4 2017 | $374,000 | +23.0% | 23,973 | -27.4% | 0.04% | -50.6% |
| Q2 2017 | $304,000 | -38.0% | 33,017 | -42.4% | 0.08% | +31.7% |
| Q1 2017 | $490,000 | – | 57,311 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |